Biotech Recursion Receives ISS ESG Prime Rating and Plans to Participate in the Goldman Sachs Global Sustainability Forum August 18, 2022
Biotech Cocrystal Pharma Engages CRO to Conduct Phase 2a Human Challenge Influenza A Clinical Trial with Novel, Broad-Spectrum Antiviral Candidate CC-42344 August 9, 2022
Biotech Xenon Pharmaceuticals to Present at the 13th Annual Wedbush PacGrow Healthcare Conference August 9, 2022
Biotech Veru Announces Presentation of Phase 3 Study of Sabizabulin for the Treatment of Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome at the 11th International Conference on Emerging Infectious Diseases (ICEID) on August 7-10, 2022 August 9, 2022
Biotech Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Executive Officer August 9, 2022
Biotech Chinook Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results August 9, 2022
Biotech Celldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update August 9, 2022